Enzo Biochem Inc
ENZBDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000316253
Enzo Biochem Inc was delisted in 2025; its insiders filed their last Form 4 on Aug 20, 2025; 41 institutions reported holding it in 13F filings for Q1 2025, worth $4.96M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Enzo Biochem Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Enzo Biochem Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Pully Steven J | Director | 0 | Aug 20, 2025 | 0 |
| Couchman Jonathan | Director | 0Indirect | Aug 20, 2025 | 0 |
| Radoff Bradley Louis | Director | 0Indirect | Aug 20, 2025 | 0 |
| Cannon Kara | Chief Executive Officer | 0Indirect | Aug 20, 2025 | 0 |
| Eckert Patricia | Chief Financial Officer | 0Indirect | Aug 20, 2025 | 0 |
| Tagliaferri Mary | Director | 312,383 | Feb 2, 2024 | 0 |
| Wolf James G. | Other: 10% owner until 2/13/2023 | 115,000Indirect | Feb 13, 2023 | 0 |
| Walters Ian B. | Director | 155,917 | Feb 13, 2023 | 0 |
| Erfanian Hamid | Chief Executive Officer | 374,600 | Nov 28, 2022 | 0 |
| Bench David | Chief Financial Officer | 6,000Indirect | Jun 15, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2023 (view filing)9:41 PM ET | Feb 10-13 | 3 days | Wolf James G.Other: 10% owner until 2/13/2023 | PPurchaseCommon Stock, $0.01 par value | +10.0K | $1.29 | +$12.9K | +0.2%4.10M after | 2 lots |
| Feb 13, 2023 (view filing)9:41 PM ET | Feb 13 | Same day | Wolf James G.Other: 10% owner until 2/13/2023 | PPurchaseCommon Stock, $0.01 par value | +5.00K | $1.29 | +$6.45K | +4.5%115.0K after | |
| Feb 13, 2023 (view filing)9:41 PM ET | Feb 13 | Same day | Wolf James G.Other: 10% owner until 2/13/2023 | SSaleCommon Stock, $0.01 par value | −107.4K | $0.0008 | −$84.06 | –0 after | Derivative2 lots |
| Feb 13, 2023 (view filing)9:41 PM ET | Feb 13 | Same day | Wolf James G.Other: 10% owner until 2/13/2023 | SSaleCommon Stock, $0.01 par value | +107.4K | $0.0109 | +$1.17K | –2.16K after | Derivative2 lots |
| Jan 30, 2023 (view filing) | Jan 27 | 3 days | Wolf James G.10% Owner | PPurchaseCommon Stock, $0.01 par value | +11.8K | $1.40 | +$16.5K | +0.3%4.09M after | |
| Jan 19, 2023 (view filing)2:37 PM ET | Oct 31-Nov 1, 2022 | 80 daysLate | Wolf James G.10% Owner | PPurchaseCommon Stock, $0.01 par value | +23.0K | $2.15 | +$49.4K | +5.8%418.5K after | 3 lots |
| Jan 19, 2023 (view filing)2:37 PM ET | Nov 1-3, 2022 | 79 daysLate | Wolf James G.10% Owner | PPurchaseCommon Stock, $0.01 par value | +154.0K | $0.0048 | +$738 | –1.70K after | Derivative5 lots |
| Jan 19, 2023 (view filing)2:37 PM ET | Nov 1-Dec 15, 2022 | 79 daysLate | Wolf James G.10% Owner | SSaleCommon Stock, $0.01 par value | +205.1K | $0.0082 | +$1.67K | –1.75K after | Derivative9 lots |
| Jan 19, 2023 (view filing)2:37 PM ET | Dec 5-30, 2022 | 45 daysLate | Wolf James G.10% Owner | SSaleCommon Stock, $0.01 par value | −70.6K | $0.0018 | −$128.15 | –3.24K after | Derivative4 lots |
| Nov 28, 2022 (view filing) | Nov 23 | 5 days | Erfanian HamidChief Executive Officer | PPurchaseCommon Stock, $0.01 Par Value | +100.0K | $1.97 | +$197.0K | +36.4%374.6K after | |
| Jul 19, 2022 (view filing) | Jul 15 | 4 days | Cannon KaraChief Operating Officer | PPurchaseCommon Stock, $0.01 Par Value | +2.50K | $2.42 | +$6.05K | New position2.50K after | |
| Jul 13, 2022 (view filing) | Jul 12 | 1 day | Radoff Bradley LouisDirector | PPurchaseCommon Stock, $0.01 Par Value | +12.5K | $2.27 | +$28.4K | +0.3%4.19M after | |
| Jul 6, 2022 (view filing) | Jul 5 | 1 day | Radoff Bradley LouisDirector | PPurchaseCommon Stock, $0.01 Par Value | +120.0K | $2.20 | +$264.0K | +3.0%4.18M after | |
| Jun 17, 2022 (view filing) | Jun 15 | 2 days | Erfanian HamidChief Executive Officer | PPurchaseCommon Stock, $0.01 Par Value | +4.60K | $2.19 | +$10.1K | +1.7%274.6K after | |
| Jun 16, 2022 (view filing) | Jun 15-16 | 1 day | Radoff Bradley LouisDirector | PPurchaseCommon Stock, $0.01 Par Value | +125.0K | $2.20 | +$275.5K | +3.2%3.99M after | 2 lots |
| Jun 15, 2022 (view filing) | Jun 14 | 1 day | Bench DavidChief Financial Officer | PPurchaseCommon Stock, $0.01 Par Value | +3.50K | $2.15 | +$7.53K | +140.0%6.00K after |